User Site Testing Study to Evaluate Usability of the Q300™ Device Under "Real-life Conditions" in a Reproductive Laboratory Environment Use

Inclusion Criteria: * Patient intended for ICSI recruited from the hospital's IVF (both male and female are considered patients in this study). * Male, Age \>18 yrs * Female age \< 40 yrs * Patients signed informed consent prior study procedures. * Fresh Oocytes * Fresh ejaculated motile sperm and presence of motile sperm at the time of sperm selection for ICSI * Fresh oocytes * Non severe male factor (TMC\>1\*10\^6/mL) * Unexplained factor infertility * AFC \>=13mm during ovarian stimulation prior to ovulation trigger or induction#\>=5 in the cycle Exclusion Criteria: * Frozen spermatozoa * Immotile sperm * Severe Oligozoospermia (less than 1 million sperm cells after preparation). * Spermatozoa extracted by TESA/ TESE * Frozen oocytes * Egg or ovulatory female factor such as low ovarian reserve (menstrual cycle, per AFC. AMH test- if performed) or non-typical eggs or eggs with severe pathology (qualitative; please find * That the instructions for use of Q300TM have not been fully followed (poor quality of images etc…) * Inability to reliably trace sperm-oocyte-embryo clinical outcome throughout the process.